NM_003265.3:c.919T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003265.3(TLR3):​c.919T>G​(p.Tyr307Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.002 in 1,614,100 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 34 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 27 hom. )

Consequence

TLR3
NM_003265.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0700

Publications

9 publications found
Variant links:
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
TLR3 Gene-Disease associations (from GenCC):
  • immunodeficiency 83, susceptibility to viral infections
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062334836).
BP6
Variant 4-186082605-T-G is Benign according to our data. Variant chr4-186082605-T-G is described in ClinVar as Benign. ClinVar VariationId is 470486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0104 (1586/152242) while in subpopulation AFR AF = 0.0365 (1515/41528). AF 95% confidence interval is 0.035. There are 34 homozygotes in GnomAd4. There are 753 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR3NM_003265.3 linkc.919T>G p.Tyr307Asp missense_variant Exon 4 of 5 ENST00000296795.8 NP_003256.1 O15455-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR3ENST00000296795.8 linkc.919T>G p.Tyr307Asp missense_variant Exon 4 of 5 1 NM_003265.3 ENSP00000296795.3 O15455-1

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1568
AN:
152124
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00575
GnomAD2 exomes
AF:
0.00269
AC:
675
AN:
250906
AF XY:
0.00207
show subpopulations
Gnomad AFR exome
AF:
0.0368
Gnomad AMR exome
AF:
0.00179
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00113
AC:
1646
AN:
1461858
Hom.:
27
Cov.:
37
AF XY:
0.000953
AC XY:
693
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.0378
AC:
1267
AN:
33480
American (AMR)
AF:
0.00179
AC:
80
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000927
AC:
8
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000845
AC:
94
AN:
1111996
Other (OTH)
AF:
0.00295
AC:
178
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
105
210
316
421
526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1586
AN:
152242
Hom.:
34
Cov.:
32
AF XY:
0.0101
AC XY:
753
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0365
AC:
1515
AN:
41528
American (AMR)
AF:
0.00314
AC:
48
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68028
Other (OTH)
AF:
0.00569
AC:
12
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00457
Hom.:
22
Bravo
AF:
0.0119
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0332
AC:
146
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00345
AC:
419
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
8.9
DANN
Benign
0.43
DEOGEN2
Benign
0.026
T;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.76
T;T
MetaRNN
Benign
0.0062
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.60
N;.
PhyloP100
0.070
PrimateAI
Benign
0.40
T
PROVEAN
Benign
1.4
N;N
REVEL
Benign
0.041
Sift
Benign
0.60
T;T
Sift4G
Benign
0.93
T;T
Polyphen
0.0010
B;.
Vest4
0.16
MVP
0.74
MPC
0.24
ClinPred
0.0068
T
GERP RS
2.6
Varity_R
0.14
gMVP
0.61
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5743317; hg19: chr4-187003759; API